1 Introduction to Research & Analysis Reports
1.1 Anticholinergic Travel Sickness Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticholinergic Travel Sickness Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticholinergic Travel Sickness Drugs Overall Market Size
2.1 Global Anticholinergic Travel Sickness Drugs Market Size: 2022 VS 2029
2.2 Global Anticholinergic Travel Sickness Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anticholinergic Travel Sickness Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anticholinergic Travel Sickness Drugs Players in Global Market
3.2 Top Global Anticholinergic Travel Sickness Drugs Companies Ranked by Revenue
3.3 Global Anticholinergic Travel Sickness Drugs Revenue by Companies
3.4 Global Anticholinergic Travel Sickness Drugs Sales by Companies
3.5 Global Anticholinergic Travel Sickness Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anticholinergic Travel Sickness Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anticholinergic Travel Sickness Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anticholinergic Travel Sickness Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anticholinergic Travel Sickness Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anticholinergic Travel Sickness Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anticholinergic Travel Sickness Drugs Market Size Markets, 2022 & 2029
4.1.2 Adults
4.1.3 Children
4.2 By Type – Global Anticholinergic Travel Sickness Drugs Revenue & Forecasts
4.2.1 By Type – Global Anticholinergic Travel Sickness Drugs Revenue, 2018-2023
4.2.2 By Type – Global Anticholinergic Travel Sickness Drugs Revenue, 2024-2029
4.2.3 By Type – Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Anticholinergic Travel Sickness Drugs Sales & Forecasts
4.3.1 By Type – Global Anticholinergic Travel Sickness Drugs Sales, 2018-2023
4.3.2 By Type – Global Anticholinergic Travel Sickness Drugs Sales, 2024-2029
4.3.3 By Type – Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Anticholinergic Travel Sickness Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anticholinergic Travel Sickness Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Other
5.2 By Application – Global Anticholinergic Travel Sickness Drugs Revenue & Forecasts
5.2.1 By Application – Global Anticholinergic Travel Sickness Drugs Revenue, 2018-2023
5.2.2 By Application – Global Anticholinergic Travel Sickness Drugs Revenue, 2024-2029
5.2.3 By Application – Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Anticholinergic Travel Sickness Drugs Sales & Forecasts
5.3.1 By Application – Global Anticholinergic Travel Sickness Drugs Sales, 2018-2023
5.3.2 By Application – Global Anticholinergic Travel Sickness Drugs Sales, 2024-2029
5.3.3 By Application – Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Anticholinergic Travel Sickness Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anticholinergic Travel Sickness Drugs Market Size, 2022 & 2029
6.2 By Region – Global Anticholinergic Travel Sickness Drugs Revenue & Forecasts
6.2.1 By Region – Global Anticholinergic Travel Sickness Drugs Revenue, 2018-2023
6.2.2 By Region – Global Anticholinergic Travel Sickness Drugs Revenue, 2024-2029
6.2.3 By Region – Global Anticholinergic Travel Sickness Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Anticholinergic Travel Sickness Drugs Sales & Forecasts
6.3.1 By Region – Global Anticholinergic Travel Sickness Drugs Sales, 2018-2023
6.3.2 By Region – Global Anticholinergic Travel Sickness Drugs Sales, 2024-2029
6.3.3 By Region – Global Anticholinergic Travel Sickness Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.4.2 By Country – North America Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.4.3 US Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.4.4 Canada Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.4.5 Mexico Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.5.3 Germany Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.4 France Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.5 U.K. Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.6 Italy Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.7 Russia Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.5.9 Benelux Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.6.3 China Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.4 Japan Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.5 South Korea Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.6.7 India Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.7.2 By Country – South America Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.7.3 Brazil Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.7.4 Argentina Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anticholinergic Travel Sickness Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anticholinergic Travel Sickness Drugs Sales, 2018-2029
6.8.3 Turkey Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8.4 Israel Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
6.8.6 UAE Anticholinergic Travel Sickness Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Baxter International
7.2.1 Baxter International Company Summary
7.2.2 Baxter International Business Overview
7.2.3 Baxter International Anticholinergic Travel Sickness Drugs Major Product Offerings
7.2.4 Baxter International Anticholinergic Travel Sickness Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Baxter International Key News & Latest Developments
8 Global Anticholinergic Travel Sickness Drugs Production Capacity, Analysis
8.1 Global Anticholinergic Travel Sickness Drugs Production Capacity, 2018-2029
8.2 Anticholinergic Travel Sickness Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anticholinergic Travel Sickness Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anticholinergic Travel Sickness Drugs Supply Chain Analysis
10.1 Anticholinergic Travel Sickness Drugs Industry Value Chain
10.2 Anticholinergic Travel Sickness Drugs Upstream Market
10.3 Anticholinergic Travel Sickness Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anticholinergic Travel Sickness Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の抗コリン性酔い止め薬市場予測2023-2029：大人用、小人用 |
| 【英語タイトル】Anticholinergic Travel Sickness Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5673 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：76 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の抗コリン性酔い止め薬市場規模と予測を収録しています。・世界の抗コリン性酔い止め薬市場：売上、2018年-2023年、2024年-2029年 ・世界の抗コリン性酔い止め薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の抗コリン性酔い止め薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「大人用」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 抗コリン性酔い止め薬のグローバル主要企業は、GlaxoSmithKline、 Baxter Internationalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、抗コリン性酔い止め薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の抗コリン性酔い止め薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の抗コリン性酔い止め薬市場：タイプ別市場シェア、2022年 ・大人用、小人用 世界の抗コリン性酔い止め薬市場：用途別、2018年-2023年、2024年-2029年 世界の抗コリン性酔い止め薬市場：用途別市場シェア、2022年 ・病院、ドラッグストア、その他 世界の抗コリン性酔い止め薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の抗コリン性酔い止め薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における抗コリン性酔い止め薬のグローバル売上、2018年-2023年 ・主要企業における抗コリン性酔い止め薬のグローバル売上シェア、2022年 ・主要企業における抗コリン性酔い止め薬のグローバル販売量、2018年-2023年 ・主要企業における抗コリン性酔い止め薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 GlaxoSmithKline、 Baxter International ************************************************************* ・調査・分析レポートの概要 抗コリン性酔い止め薬市場の定義 市場セグメント 世界の抗コリン性酔い止め薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の抗コリン性酔い止め薬市場規模 世界の抗コリン性酔い止め薬市場規模：2022年 VS 2029年 世界の抗コリン性酔い止め薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの抗コリン性酔い止め薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の抗コリン性酔い止め薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：大人用、小人用 抗コリン性酔い止め薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、ドラッグストア、その他 抗コリン性酔い止め薬の用途別グローバル売上・予測 ・地域別市場分析 地域別抗コリン性酔い止め薬市場規模 2022年と2029年 地域別抗コリン性酔い止め薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） GlaxoSmithKline、 Baxter International ... |
Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
This report aims to provide a comprehensive presentation of the global market for Anticholinergic Travel Sickness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticholinergic Travel Sickness Drugs. This report contains market size and forecasts of Anticholinergic Travel Sickness Drugs in global, including the following market information:
Global Anticholinergic Travel Sickness Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anticholinergic Travel Sickness Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Anticholinergic Travel Sickness Drugs companies in 2022 (%)
The global Anticholinergic Travel Sickness Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Adults Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anticholinergic Travel Sickness Drugs include GlaxoSmithKline and Baxter International etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticholinergic Travel Sickness Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticholinergic Travel Sickness Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, by Type, 2022 (%)
Adults
Children
Global Anticholinergic Travel Sickness Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Drugstores
Other
Global Anticholinergic Travel Sickness Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Anticholinergic Travel Sickness Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticholinergic Travel Sickness Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anticholinergic Travel Sickness Drugs revenues share in global market, 2022 (%)
Key companies Anticholinergic Travel Sickness Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Anticholinergic Travel Sickness Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Baxter International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticholinergic Travel Sickness Drugs, market overview.
Chapter 2: Global Anticholinergic Travel Sickness Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anticholinergic Travel Sickness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticholinergic Travel Sickness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anticholinergic Travel Sickness Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の抗コリン性酔い止め薬市場予測2023-2029：大人用、小人用] (コード：MMG23JU5673)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の抗コリン性酔い止め薬市場予測2023-2029：大人用、小人用]についてメールでお問い合わせ |
